Canaccord Initiates Coverage of Biohaven Ltd. (BHVN) With a Buy Rating [Yahoo! Finance]
Biohaven Ltd. Common Shares (BHVN)
Last biohaven ltd. common shares earnings: 2/25 04:45 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.biohavenpharma.com
Company Research
Source: Yahoo! Finance
Ltd. (NYSE:BHVN) with a Buy rating and set a $21 price target on the stock. The firm told investors in a research note that the company is in the process of developing novel therapeutics for obesity, immunology, neuroscience, and oncology indications. Canaccord views the stock as undervalued based on the company's opakalim opportunity alone, and recommends buying the shares into the focal epilepsy readout, which the firm sees as presenting “significant upside potential.” Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” Biohaven Ltd. (NYSE:BHVN) also received a rating update from Citi on April 2, with the firm lifting the price target on the stock to $17 from $14 while maintaining a Buy rating on the shares. The firm told investors that it sees an attractive risk/reward at current share levels into the company's 2026 catalysts. It also said that it sees the recent competitor data in focal epilepsy to be very positive for the company's Phase 3 opakalim trial, which h
Show less
Read more
Impact Snapshot
Event Time:
BHVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHVN alerts
High impacting Biohaven Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics
BHVN
News
- Biohaven (BHVN) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=BHVN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "strong sell" toMarketBeat
- Biohaven: Downgrade To Hold On Troriluzole Setback And Obesity Data 2nd Half 2026 [Seeking Alpha]Seeking Alpha
- Why Biohaven Stock Crushed it on Monday [Yahoo! Finance]Yahoo! Finance
- Why Biohaven Stock Crushed it on Monday [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Biohaven (BHVN) is now covered by Canaccord Genuity Group Inc.. They set a "buy" rating and a $21.00 price target on the stock.MarketBeat
BHVN
Earnings
- 3/2/26 - Beat
BHVN
Sec Filings
- 3/19/26 - Form 4
- 3/13/26 - Form DEFA14A
- 3/13/26 - Form DEF
- BHVN's page on the SEC website